Belite Bio (BLTE) Return on Capital Employed Growth (1y) (2024 - 2025)

Belite Bio (BLTE) Return on Capital Employed Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 1,648.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 31,429.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1,805.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2,503.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -105.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -3,457.00
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 2,400.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -296.36 Mn
Dec 31, 2024 430,122.00